A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may ...
A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may ...
Hosted on MSN
Majority of Medicaid managed care plans cover opioid overdose reversal drug naloxone, but access barriers remain
In 2023, the US Food and Drug Administration approved the overdose reversal drug naloxone, commonly known as Narcan, for over-the-counter (OTC) use. While hailed as a public health success for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results